UNIVERSE PHARMACEUTICAL-CL A (UPC) Forecast, Price Target & Analyst Ratings
NASDAQ:UPC • KYG9442G1385
2.65 USD
-0.07 (-2.57%)
At close: Mar 9, 2026
2.15 USD
-0.5 (-18.87%)
After Hours: 3/9/2026, 8:00:02 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for UNIVERSE PHARMACEUTICAL-CL A (UPC).
Forecast Snapshot
Consensus Price Target
N/A
N/A
Next Earnings Forecast
Release DateN/A
ChartMill Buy Consensus
0.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $2.65 to mean target of N/A, Based on 0 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
0.00%
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 32.309M -19.51% | 23.025M -28.74% | 17.859M -22.44% | |
| EBITDA YoY % growth | -3.457M 49.97% | -7.534M -117.92% | -2.399M 68.16% | |
| EBIT YoY % growth | -3.966M 46.69% | -8.02M -102.21% | -2.916M 63.64% | |
| Operating Margin | -12.28% | -34.83% | -16.33% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A